Valera V - Search Results

1

Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy.

Girardi DM, Niglio SA, Mortazavi A, Nadal R, Lara P, Pal SK, Saraiya B, Cordes L, Ley L, Ortiz OS, Cadena J, Diaz C, Bagheri H, Redd B, Steinberg SM, Costello R, Chan KS, Lee MJ, Lee S, Yu Y, Gurram S, Chalfin HJ, Valera V, Figg WD, Merino M, Toubaji A, Streicher H, Wright JJ, Sharon E, Parnes HL, Ning YM, Bottaro DP, Cao L, Trepel JB, Apolo AB. Girardi DM, et al. Among authors: valera v. Clin Cancer Res. 2022 Apr 1;28(7):1353-1362. doi: 10.1158/1078-0432.CCR-21-3726. Clin Cancer Res. 2022. PMID: 35031545 Free PMC article.

2

Tumor suppressor FLCN inhibits tumorigenesis of a FLCN-null renal cancer cell line and regulates expression of key molecules in TGF-beta signaling.

Hong SB, Oh H, Valera VA, Stull J, Ngo DT, Baba M, Merino MJ, Linehan WM, Schmidt LS. Hong SB, et al. Mol Cancer. 2010 Jun 23;9:160. doi: 10.1186/1476-4598-9-160. Mol Cancer. 2010. PMID: 20573232 Free PMC article.

3

Protein expression profiling in the spectrum of renal cell carcinomas.

Valera VA, Li-Ning-T E, Walter BA, Roberts DD, Linehan WM, Merino MJ. Valera VA, et al. J Cancer. 2010 Oct 14;1:184-96. doi: 10.7150/jca.1.184. J Cancer. 2010. PMID: 20975849 Free PMC article.

4

miR-21 Expression in Pregnancy-Associated Breast Cancer: A Possible Marker of Poor Prognosis.

Walter BA, Gómez-Macias G, Valera VA, Sobel M, Merino MJ. Walter BA, et al. J Cancer. 2011 Feb 7;2:67-75. doi: 10.7150/jca.2.67. J Cancer. 2011. PMID: 21326627 Free PMC article.

5

Misdiagnosis of clear cell renal cell carcinoma.

Valera VA, Merino MJ. Valera VA, et al. Nat Rev Urol. 2011 May 17;8(6):321-33. doi: 10.1038/nrurol.2011.64. Nat Rev Urol. 2011. PMID: 21587224 Review.

6

Regulatory Effects of microRNA-92 (miR-92) on VHL Gene Expression and the Hypoxic Activation of miR-210 in Clear Cell Renal Cell Carcinoma.

Valera VA, Walter BA, Linehan WM, Merino MJ. Valera VA, et al. J Cancer. 2011;2:515-26. doi: 10.7150/jca.2.515. Epub 2011 Oct 21. J Cancer. 2011. PMID: 22043236 Free PMC article.

7

A novel fumarate hydratase-deficient HLRCC kidney cancer cell line, UOK268: a model of the Warburg effect in cancer.

Yang Y, Valera V, Sourbier C, Vocke CD, Wei M, Pike L, Huang Y, Merino MA, Bratslavsky G, Wu M, Ricketts CJ, Linehan WM. Yang Y, et al. Among authors: valera v. Cancer Genet. 2012 Jul-Aug;205(7-8):377-90. doi: 10.1016/j.cancergen.2012.05.001. Cancer Genet. 2012. PMID: 22867999 Free PMC article.

8

Adrenal nodular hyperplasia in hereditary leiomyomatosis and renal cell cancer.

Shuch B, Ricketts CJ, Vocke CD, Valera VA, Chen CC, Gautam R, Gupta GN, Gomez Macias GS, Merino MJ, Bratslavsky G, Linehan WM. Shuch B, et al. J Urol. 2013 Feb;189(2):430-5. doi: 10.1016/j.juro.2012.07.139. Epub 2012 Sep 19. J Urol. 2013. PMID: 22982371 Free PMC article.

9

Comprehensive microRNA Profiling of Prostate Cancer.

Walter BA, Valera VA, Pinto PA, Merino MJ. Walter BA, et al. J Cancer. 2013 May 9;4(5):350-7. doi: 10.7150/jca.6394. Print 2013. J Cancer. 2013. PMID: 23781281 Free PMC article.

10

Predicting Gleason Group Progression for Men on Prostate Cancer Active Surveillance: Role of a Negative Confirmatory Magnetic Resonance Imaging-Ultrasound Fusion Biopsy.

Bloom JB, Hale GR, Gold SA, Rayn KN, Smith C, Mehralivand S, Czarniecki M, Valera V, Wood BJ, Merino MJ, Choyke PL, Parnes HL, Turkbey B, Pinto PA. Bloom JB, et al. Among authors: valera v. J Urol. 2019 Jan;201(1):84-90. doi: 10.1016/j.juro.2018.07.051. J Urol. 2019. PMID: 30577395 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters